Discovery & Development

Could a new nasal delivery method finally get drugs to the central nervous system?

Unravelling the challenges and trends in formulation best practice – and why softgels and lipids are leading the way

Nine years ago we set out to characterize and evaluate our raw materials - this is what we found out…

Scaling up a bioprocess doesn’t need to be a headache - especially when there are firms out there that can lend a helping hand

Today's small molecules are increasingly complex, but generic producers must keep track of trends

Sitting Down With… Abhijit Mukherjee, COO of Dr. Reddy's Laboratories, India

Drugs often fail , both before and after reaching the market - but why?

One of the biggest pharma trade shows in Europe kicks off at the end of October

Each new drug is unique and deserves a fresh approach to formulation.

Why stop at biosimilar when you can be biobetter?